Guohua Xi Selected Research

Intraventricular Injections

1/2021	Cerebrospinal Fluid from Aneurysmal Subarachnoid Hemorrhage Patients Leads to Hydrocephalus in Nude Mice.
2/2020	Effects of aging on hydrocephalus after intraventricular hemorrhage.
1/2020	Prx2 (Peroxiredoxin 2) as a Cause of Hydrocephalus After Intraventricular Hemorrhage.
1/2016	Intraventricular Injection of Noncellular Cerebrospinal Fluid from Subarachnoid Hemorrhage Patient into Rat Ventricles Leads to Ventricular Enlargement and Periventricular Injury.
1/2016	Effects of Aerobic Capacity on Thrombin-Induced Hydrocephalus and White Matter Injury.
12/2014	Role of hemoglobin and iron in hydrocephalus after neonatal intraventricular hemorrhage.
10/2014	Deferoxamine attenuates acute hydrocephalus after traumatic brain injury in rats.
3/2014	Hydrocephalus after intraventricular hemorrhage: the role of thrombin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guohua Xi Research Topics

Disease

92	Cerebral Hemorrhage 10/2022 - 01/2002
75	Brain Injuries (Brain Injury) 10/2022 - 01/2002
54	Brain Edema (Cerebral Edema) 01/2021 - 02/2002
32	Hematoma 03/2022 - 01/2002
21	Hydrocephalus (Hydrocephaly) 05/2022 - 01/2011
19	Hemorrhage 05/2022 - 09/2005
15	Brain Ischemia (Cerebral Ischemia) 01/2019 - 04/2002
13	Edema (Dropsy) 10/2022 - 02/2002
13	Atrophy 02/2022 - 02/2006
12	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2021 - 07/2008
12	Stroke (Strokes) 01/2021 - 02/2004
11	Infarction (Infarctions) 02/2018 - 04/2002
9	Neuroinflammatory Diseases 04/2022 - 09/2015
9	Iron Overload 01/2020 - 12/2003
6	Inflammation (Inflammations) 05/2022 - 01/2006
6	Ischemic Stroke 01/2021 - 02/2009
5	Hemorrhagic Stroke 01/2022 - 01/2013
5	Hypoxia (Hypoxemia) 03/2016 - 06/2002
5	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 07/2012 - 04/2005
4	Thrombosis (Thrombus) 01/2022 - 12/2002
4	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2016 - 01/2003
4	Glioma (Gliomas) 01/2016 - 01/2008
3	Ischemia 11/2019 - 09/2009
3	Aneurysm (Aneurysms) 11/2016 - 07/2014
3	Intracranial Hemorrhages (Intracranial Hemorrhage) 03/2016 - 08/2014
3	Neurologic Manifestations (Neurological Manifestations) 09/2015 - 02/2004
3	Parkinson Disease (Parkinson's Disease) 11/2007 - 01/2005
2	Nervous System Diseases (Neurological Disorders) 01/2021 - 01/2002
2	Hemolysis 01/2020 - 01/2017
2	Neoplasms (Cancer) 01/2016 - 01/2008
2	Necrosis 01/2011 - 03/2006
2	Hyperglycemia 09/2009 - 04/2007
1	Cognitive Dysfunction 02/2022
1	Intracranial Thrombosis (Cerebral Thrombosis) 01/2021
1	Weight Loss (Weight Reduction) 01/2021

Drug/Important Bio-Agent (IBA)

60	IronIBA 10/2022 - 02/2002
42	Thrombin FDA Link 04/2022 - 01/2002
26	Hemoglobins (Hemoglobin)IBA 10/2022 - 02/2002
26	Deferoxamine (Desferal)FDA LinkGeneric 03/2022 - 02/2002
16	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2002
10	Lipocalin-2IBA 01/2022 - 04/2013
9	Minocycline (Cyclops)FDA LinkGeneric 05/2022 - 03/2009
7	Ferritins (Ferritin)IBA 01/2021 - 12/2003
7	Peptide Hydrolases (Proteases)FDA Link 12/2016 - 10/2006
7	salicylhydroxamic acid (SHAM)IBA 01/2016 - 04/2005
7	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2011 - 01/2002
6	Liposomes (Liposome)IBA 05/2022 - 02/2016
6	Clodronic Acid (Clodronate)IBA 05/2022 - 02/2016
6	Heme Oxygenase-1IBA 10/2021 - 12/2003
6	PeroxiredoxinsIBA 01/2021 - 01/2020
6	Chelating AgentsIBA 01/2019 - 02/2002
5	Complement System Proteins (Complement)IBA 04/2022 - 07/2005
5	Thrombin Receptors (Thrombin Receptor)IBA 01/2016 - 04/2002
4	Estrogens (Estrogen)FDA Link 01/2022 - 07/2005
4	Glucose (Dextrose)FDA LinkGeneric 02/2018 - 04/2007
4	Oxygen (Dioxygen)IBA 02/2018 - 04/2007
3	CytokinesIBA 04/2022 - 03/2009
3	Eosine Yellowish-(YS) (Eosin)IBA 01/2022 - 01/2011
3	Hematoxylin (Haematoxylon)IBA 01/2022 - 01/2011
3	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 01/2021 - 01/2016
3	PlatinumIBA 11/2016 - 07/2014
3	EnzymesIBA 03/2016 - 01/2016
3	Heme (Haem)IBA 01/2016 - 12/2006
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2014 - 03/2006
3	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2013 - 11/2004
3	Messenger RNA (mRNA)IBA 01/2013 - 01/2002
3	Mitogen-Activated Protein KinasesIBA 01/2013 - 09/2009
3	Collagenases (Collagenase)FDA Link 06/2011 - 12/2002
3	argatroban (MPQA)FDA Link 01/2008 - 12/2002
3	Oxidopamine (6 Hydroxydopamine)IBA 11/2007 - 01/2005
3	Transferrin (beta 2 Transferrin)IBA 02/2005 - 12/2003
2	AlbuminsIBA 01/2021 - 01/2013
2	Complement C3 (C3 Complement)IBA 01/2021 - 12/2006
2	Hemin (Panhematin)FDA Link 01/2019 - 01/2011
2	Neuroprotective AgentsIBA 11/2016 - 01/2011
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2016 - 01/2009
2	ImmunosorbentsIBA 01/2016 - 01/2016
2	Estrogen ReceptorsIBA 01/2016 - 07/2005
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016 - 09/2009
2	Fulvestrant (Faslodex)FDA Link 01/2016 - 07/2005
2	Tamoxifen FDA LinkGeneric 01/2016 - 01/2011
2	Protein Glutamine gamma Glutamyltransferase 2IBA 01/2011 - 01/2009
2	Evans Blue (Blue, Evans)FDA Link 01/2011 - 04/2007
2	2- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA 09/2009 - 05/2007
2	Complement C5 (Complement 5)IBA 12/2006 - 05/2004
2	HirudinsIBA 02/2004 - 01/2002
2	Transferrin Receptors (Transferrin Receptor)IBA 12/2003 - 12/2003
1	NeurotoxinsIBA 10/2022
1	Laminin (Merosin)IBA 01/2022
1	Fibrinogen (Factor I)FDA Link 01/2022
1	Myelin Basic ProteinIBA 10/2021
1	Prothrombin (Factor II)IBA 01/2021
1	Proteinase-Activated ReceptorsIBA 01/2021
1	Immunoglobulin G (IgG)IBA 01/2020
1	conoidin AIBA 01/2020

Therapy/Procedure

15	Therapeutics 11/2019 - 12/2002
8	Intraventricular Injections 01/2021 - 03/2014
2	Injections 08/2021 - 01/2021
2	Minimally Invasive Surgical Procedures 01/2020 - 01/2018
2	Catheters 01/2018 - 07/2002